Phenylpyruvate

Phenylpyruvate

SCHEMBL3408866

O=C(O)C(=O)Cc1ccccc1.[CaH2]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 3/20 0.76
▸ CES2 O00748 2/20 0.76
▸ FNTA P49354 2/20 0.61
▸ FNTB P49356 2/20 0.61
▸ AKR1B1 P15121 1/20 0.61
▸ F2 P00734 2/20 0.55
▸ CTBP2 P56545 1/20 0.54
▸ PLG P00747 1/20 0.53
▸ PRSS1 P07477 1/20 0.53
▸ PRSS2 P07478 1/20 0.53
▸ C1S P09871 1/20 0.53
▸ PRSS3 P35030 1/20 0.53
▸ MEN1 O00255 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylpyruvate SCHEMBL43235 0.97 CES1 (0.80) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28203540 0.97 CES1 (0.80) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28232350 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28233246 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28233232 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL468389 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL27281240 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL9217988 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL11193388 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL6850951 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020244798-A1 METHOD FOR TASTE/ODOR MASKING OF A PRODUCT FOR CHRONIC KIDNEY DISEASE PATIENTS ATHENION AG (CH) 2020-12-10 — — WO claimed
CN-109588554-A It is a kind of to utilize waste bamboo shell solid state fermentation production biological feedstuff and preparation method thereof 浙江皇冠科技有限公司 2019-04-09 — — CN claimed
CN-108384210-A A kind of application of pyruvates and polydactyl acid 中国科学院长春应用化学研究所 2018-08-10 — — CN claimed
WO-2012137216-A1 A NOVEL PHARMACEUTICAL FORMULATION OF ALPHA KETOANALOGUE OF AMINO ACIDS AND ADDITIONAL AMINO ACIDS FOR TREATMENT OF CHRONIC KIDNEY DISEASE AND METHOD OF PREPARATION THEREOF RPG LIFE SCIENCES LIMITED (IN) 2012-10-11 — — WO claimed
WO-2009018368-A1 COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2009-02-05 — — WO claimed
CN-1049650-C Synthetic method of phenyl-pyruvic alkali salt and ammonium salt NANJING CHEMICAL ENGINEERING U (CN) 2000-02-23 — — CN claimed
CN-1138022-A Synthetic method of phenyl-pyruvic alkali salt and ammonium salt NANJING CHEMICAL ENGINEERING U (CN) 1996-12-18 — — CN claimed
EP-0422162-A4 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE — 1991-09-25 — — EP claimed
EP-0422162-A1 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE THE NUTRASWEET COMPANY (US) 1991-04-17 — — EP claimed
US-4997979-A Carbonylation, cobalt catalyst RHONE-POULENC CHIMIE (FR) 1991-03-05 — — US claimed
WO-1990011993-A1 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE THE NUTRASWEET COMPANY (US) 1990-10-18 — — WO claimed
US-4912255-A Process for preparing sodium phenylpyruvate from calcium phenylpyruvate NUTRASWEET COMPANY, THE 1990-03-27 — — US claimed
US-4100161-A Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids THE JOHNS HOPKINS UNIVERSITY (US) 1978-07-11 — — US claimed
US-4100160-A Therapeutic compositions comprising alpha-hydroxy analogs of essential amino acids and their administration to humans for promotion of protein synthesis and suppression of urea formation THE JOHNS HOPKINS UNIVERSITY (US) 1978-07-11 — — US claimed
JP-2022246-A — — None — — JP disclosed
US-20240258529-A1 SECONDARY BATTERY AND PREPARATION METHOD THEREOF, BATTERY MODULE, BATTERY PACK AND POWERED DEVICE CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-08-01 — — US disclosed
EP-4398348-A1 SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR, BATTERY MODULE, BATTERY PACK AND ELECTRICAL DEVICE Contemporary Amperex Technology Co., Limited (CN) 2024-07-10 — — EP disclosed
JP-H0222246-A PRODUCTION OF ALKALI PHENYLPYRUVATE RHONE POULENC CHIM 1990-01-25 — — JP disclosed
EP-0215414-A2 Process for producing L-phenylalanine Kuraray Co., Ltd. (JP) 1987-03-25 — — EP disclosed
US-4576809-A COBALT/II/COMPOUND, CARBON MONOXIDE, HYDROXIDE, SULFUR COMPOUND RHONE-POULENC SPECIALITIES CHIMIQUES (FR) 1986-03-18 — — US disclosed
Send feedback